Skip to main content
Novartis Top Menu
Novartis Top Menu
Search
Search
Menu
About Us
Board of Trustees
Joerg Reinhardt, Ph.D.
Ann Aerts, M.D.
Dr. Jo Ivey Boufford
Lutz Hegemann, M.D., Ph.D.
John Kahan
Prof. Peter Piot, M.D.
Our partners
About Us
Transforming population health
CARDIO4Cities
AI4BetterHearts
AI4HealthyCities
Broadband Commission Working Group on Digital and AI in Health
HealthTech Innovation
Brazil COVID-19 response
AI4Leprosy
Transforming Population Health
Urban Population Health Toolkit
Quality of care
Ensure access
Policy reform
Leverage data and digital
Intersectoral collaboration
Ensure local ownership
Urban Population Health Toolkit
Past programs
Better Hearts Better Cities
Community-based Hypertension Improvement Project (ComHIP)
Communities for Healthy Hearts
KaziBantu (Healthy Schools for Healthy Communities)
Leprosy and malaria elimination
The Leprosy Alert and Response Network System (LEARNS)
Leprosy Post-Exposure Prophylaxis (LPEP) program
Malaria Targeted Parasite Elimination Strategy
Digital Health
Ghana Telemedicine
Telemedicine Toolkit
Integrated e-Diagnostic Approach
Past Programs - Mega Menu
Past Programs
Media Center
News Archive
Media Library
Stories
Media Center
Homepage
Home
Media Center
PharmExec
PharmExec
Oct 14, 2020
The COVID-19 boost to AI in global health.
Oct 14, 2020
Read More
Print
PDF